Dr. Nathan Katz Adipose Seminar at TOBI
Excerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.
Read more
Excerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.
Read more
Orthopedic surgery presents hope – and risks. There are alternatives, including microfat, that should be considered.
Read more
Dr. Mitchell Sheinkop discusses Jointechlabs’ recent presentation of scientific papers at orthobiologic conferences in Europe.
Read more
Chicken soup was and is a popular cure-all. Today, joint preservation with orthobiologics such as microfragmented adipose tissue for grades 2-3 osteoarthritis is an emerging standard of care.
Read more
The rising global market for regenerative medicine not only offers hope in the form of advanced therapies but also presents a fertile ground for robust investment returns.
Read more
Renowned doctors Dr. William D. Murrell (orthopedics) and Dr. Carlos Mercado (aesthetics) bring new scientific and market savvy to the company.
Read more
BMAC and microfat both provide orthopedic advantages. Microfat can also be used when BMAC is not indicated.
Read more
“Join us on the Talk is Biotech! podcast as we chat with Nathan Katz about his incredible journey from completing his PhD to becoming a medical scientist and ultimately a successful CEO of Jointechlabs, Inc.”
Read more
Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read more
Dr. Nathan Katz discusses best practices in microfat-based procedures and the processing of microfat for optimal results.
Read more